Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is a rare but aggressive thoracic malignancy with limited treatment options. One of the standard treatments for MPM is chemotherapy, which consists of concurrent treatment with pemetrexed and cisplatin. Pemetrexed limits tumor growth by inhibiting critical metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karatkevich, Darya, Deng, Haibin, Gao, Yanyun, Flint, Emilio, Peng, Ren-Wang, Schmid, Ralph Alexander, Dorn, Patrick, Marti, Thomas Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569655/
https://www.ncbi.nlm.nih.gov/pubmed/36233258
http://dx.doi.org/10.3390/ijms231911949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569655/
https://www.ncbi.nlm.nih.gov/pubmed/36233258
http://dx.doi.org/10.3390/ijms231911949

Ejemplares similares